+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

From
From
Drugs For Hormonal Replacement Therapy Global Market Report 2024 - Product Thumbnail Image

Drugs For Hormonal Replacement Therapy Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Immuno-Oncology Clinical Trials Market Report 2023-2033 - Product Thumbnail Image

Immuno-Oncology Clinical Trials Market Report 2023-2033

  • Report
  • September 2023
  • 249 Pages
  • Global
From
From
From
From
From
Urothelial Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Urothelial Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 170 Pages
  • Global
From
Diabetic Retinopathy Treatment - Global Strategic Business Report - Product Thumbnail Image

Diabetic Retinopathy Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 273 Pages
  • Global
From
From
From
Osteoporosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Osteoporosis Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 340 Pages
  • Global
From
From
Loading Indicator